首页> 外文OA文献 >A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging--a prospective trial
【2h】

A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging--a prospective trial

机译:非小细胞肺癌分期在放射学正常的纵隔内联合支气管内镜和超声引导下穿刺针吸管的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This prospective study aimed to assess the diagnostic yield of the combined approach - endobronchial (EBUS) and endoscopic (EUS) ultrasound-guided needle aspiration (combined ultrasound-needle aspiration (CUS-NA)) in the radiologically normal mediastinum in non-small-cell lung cancer (NSCLC) staging. CUS-NA was performed simultaneously under local anaesthesia and sedation in consecutive NSCLC patients with mediastinal nodes that were not enlarged on CT (stage IA-IIB). All patients with negative CUS-NA subsequently underwent the transcervical extended bilateral mediastinal lymphadenectomy (TEMLA) as a confirmatory test. A total of 120 NSCLC patients underwent CUS-NA between 1 January 2008 and 31 December 2008. There were 318 mediastinal nodes biopsied (158 EBUS-NA - stations: 2R - 2, 2L - 1, 4R - 34, 4L - 33 and 7 - 88 and 160 EUS-NA - stations: 4L - 57, 7 - 101 and 9 - 2). CUS-NA revealed metastatic lymph node involvement in 19 of 120 patients (16%) and in 31 of 318 biopsies (10%). The prevalence was 22%. In 99 patients with negative CUS-NA, who underwent subsequent TEMLA, metastatic nodes were diagnosed in nine patients (8%) in 11 stations: 2R - 2, 4R - 4, 4L - 1, 5 - 3 and 7 - 1. In all but one patient there were 'minimal N2' only. Diagnostic sensitivity, specificity, total accuracy, positive predictive value (PPV) and negative predictive value (NPV) of CUS-NA for normal mediastinum was 68% (95% confidence interval (CI): 48-84), 98% (95% CI: 92-100), 91% (95% CI: 86-96), 91% (95% CI: 70-99) and 91% (95% CI: 83-96), respectively. The sensitivity of CUS-NA was significantly higher than with EBUS-NA alone (p=0.04) and higher, close to the level of significance than with EUS-NA alone (p=0.07). The NPV of all techniques was high and that of CUS-NA was significantly higher than EBUS-NA alone and EUS-NA alone (p=0.01, p=0.03). No complications of CUS-NA were observed. In the radiologically normal mediastinum, CUS-NA is a highly effective and safe technique in NSCLC staging and, if negative, a surgical diagnostic exploration of the mediastinum may be omitted
机译:这项前瞻性研究旨在评估联合检查在非小肠放射正常的纵隔中的诊断方法-支气管内(EBUS)和内窥镜(EUS)超声引导下的针穿刺术(超声-针刺联合穿刺术(CUS-NA))的诊断率。细胞肺癌(NSCLC)分期。对于连续纵隔淋巴结未在CT上扩大的NSCLC患者,在局部麻醉和镇静下同时进行CUS-NA(IA-IIB期)。所有CUS-NA阴性的患者随后均行经颈宫颈纵隔双侧纵隔淋巴结清扫术(TEMLA),作为确证性测试。在2008年1月1日至2008年12月31日期间,共有120例NSCLC患者接受了CUS-NA检查。活检了318个纵隔淋巴结(158个EBUS-NA-工作站:2R-2、2L-1、4R-34、4L-33和7 -88和160 EUS-NA-电台:4L-57、7-101和9-2)。 CUS-NA显示120例患者中有19例(16%)和318例活检中有31例(10%)转移了淋巴结。患病率为22%。在随后接受TEMLA的99例CUS-NA阴性患者中,在11个站中的9例(8%)患者中诊断出转移性淋巴结转移:2R-2、4R-4、4L-1、5-3和7-1。除一名患者外,所有患者均只有“最低氮”。 CUS-NA对正常纵隔的诊断敏感性,特异性,总准确性,阳性预测值(PPV)和阴性预测值(NPV)为68%(95%置信区间(CI):48-84),98%(95%) CI:92-100),91%(95%CI:86-96),91%(95%CI:70-99)和91%(95%CI:83-96)。 CUS-NA的敏感性显着高于单独使用EBUS-NA(p = 0.04),并且比单独使用EUS-NA的敏感性高(p = 0.07)。所有技术的NPV都很高,而CUS-NA的NPV明显高于单独的EBUS-NA和单独的EUS-NA(p = 0.01,p = 0.03)。没有观察到CUS-NA的并发症。在放射学正常的纵隔中,CUS-NA是非小细胞肺癌分期的一种高效且安全的技术,如果阴性,则可以省略纵隔的外科诊断检查

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号